New Treatments for Hodgkin Lymphoma Coming to ClinicsSandra Kear
Treatments and clinical burden among hodgkin lymphoma patients at high risk of relapse after autologous stem cell transplant: A literature reviewBonthapally, VAyyagari, RYang, HWu, E QShonukan, O
et al. FTL004, an anti-CD38 mAb with negligible RBC binding and enhanced pro-apoptotic activity, is a novel candidate for treatments of multiple myeloma and non-Hodgkin lymphoma. J Hematol Oncol 15, 177 (2022). https://doi.org/10.1186/s13045-022-01395-0 Download citation Received24 ...
The outcome of 70 elderly patients aged 65 years or more (median, 71 years) with non-Hodgkin's lymphoma (NHL) treated between 1973 and 1981 with aggressive (AM) or conservative modalities (CM) was retrospectively evaluated. A significantly higher incidence of lethal and severe toxicity was ...
In HIV-positive patients who develop non-Hodgkin lymphoma (NHL), it is widely accepted that outcomes can be improved by combining antiretroviral therapy with treatments directed at NHL. The clinician's armamentarium now includes highly active antiretroviral therapy (HAART), standard chemotherapy ...
Messori A, Fadda V, Maratea D, Trippoli S. Treatments for non-Hodgkin lymphoma in HIV-positive patients: quantifying incremental benefit from 1993 to 2004 by meta-regression. Am J Hematol 2013;88(5):435.Messori A, Fadda V, Maratea D, Trippoli S (2013) Treatments for non-Hodgkin ...
Improvements in Treatments for Hodgkin Lymphoma Over a 50-Year Period Lead to Fewer Second MalignanciesResponse to primary treatment in diffuse large B cell lymphoma (DLBCL) is highly predictive of long-term outcome. We evaluated the value of computed tomography (CT) findings relative to positron ...
Objective To assess sperm production and aneuploidy in Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) before and after treatments. Design Multicenter, prospective, longitudinal study of lymphoma patients analyzed before treatment and after 3, 6, 12, and 24 months. Setting University ...
These investigators found evidence for the role of an intact B-cell receptor signaling pathway in the sensitivity of cell lines to IPI-145, and efforts are under way to define specific biomarkers that identify patients with DLBCL who are sensitive to the drug. In addition, IPI-145 was ...
Objective: To assess sperm production and aneuploidy in Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) before and after treatments.Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society...